Early Exposure to Antibiotics Ups Risk of Allergic Dz Later in Life

Share this content:
Early Exposure to Antibiotics Ups Risk of Allergic Dz Later in Life
Early Exposure to Antibiotics Ups Risk of Allergic Dz Later in Life

WEDNESDAY, Sept. 7, 2016 (HealthDay News) -- Taking antibiotics at a very young age could increase the risk of certain allergic conditions later in life, according to research presented at the annual European Respiratory Society International Congress, held from Sept. 3 to 7 in London.

Fariba Ahmadizar, Pharm.D., of Utrecht University in the Netherlands, and colleagues reviewed the findings of studies published between 1996 and 2015 that included over 400,000 individuals.

The investigators found that treatment with antibiotics within the first two years of life was associated with a 15 to 41 percent increased risk of eczema and a 14 to 56 percent increased risk of hay fever later in life. Risk for both conditions was higher among those who received two courses of antibiotics than among those who received one course of antibiotics. The researchers hypothesized that antibiotics disrupt microorganisms in the gut, leading to reduced immune response.

"Early-life exposure to antibiotics is related to an increased risk of both eczema and hay fever later in life," Ahmadizar said in a news release from the European Respiratory Society.

Press Release
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Improved achievement of glycemic targets, reduced body weight

European, American Guidelines Lead to Different Recs for Statins

European, American Guidelines Lead to Different Recs for ...

Quantification of CAC score can improve stratification for those at high, low risk for events

Hyperbaric O2 Therapy Effective in Maxillary Osteoradionecrosis

Hyperbaric O<sub>2</sub> Therapy Effective in Maxillary Osteoradionecrosis

Positive clinical outcome with HBOT for 85.7 percent of patients with maxillary bone osteoradionecrosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »